ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in PCRX — Pacira BioSciences, Inc.

CIK 1164508 BOSTON, MA

Back to PCRX Full portfolio

Position in PCRX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$835,431

-$541,333 QoQ

Shares Held

36,966

-30.5% QoQ

Ownership

0.094%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in PCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $805,226,112 across 23 Drug Manufacturers - Specialty & Generic names. PCRX ranks #19 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,975,559	$233,530,829
2	HLN	Haleon plc	14,674,518	$146,891,925
3	VTRS	Viatris Inc	8,545,196	$115,445,597
4	INDV	Indivior Pharmaceuticals, Inc.	2,323,264	$70,813,086
5	TAK	Takeda Pharmaceutical Co Ltd	3,116,311	$57,714,079
6	ANIP	Ani Pharmaceuticals Inc	564,360	$43,399,284
7	KNSA	Kiniksa Pharmaceuticals International, plc	892,666	$42,981,867
8	COLL	Collegium Pharmaceutical, Inc	703,528	$23,265,670

All Filings in PCRX

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$835,431	36,966	-30.5%	Shares	Defined	2026-05-14
2025-12-31	$1,376,764	53,198	+27.3%	Shares	Defined	2026-02-13
2025-09-30	$1,077,005	41,793	+17.4%	Shares	Defined	2025-11-13
2025-06-30	$850,983	35,606	-47.3%	Shares	Defined	2025-08-13
2025-03-31	$1,679,561	67,588	-89.6%	Shares	Defined	2025-05-14
2024-12-31	$12,195,471	647,318	-43.8%	Shares	Defined	2025-02-12
2024-09-30	$17,347,006	1,152,625	+2058.1%	Shares	Defined	2024-11-14
2024-06-30	$1,528,031	53,409	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.